[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum

C54H50N4OPt-2 — CID 169066649

IUPAC[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
SMILESCC1CCN(c2cc(C(C)(C)C)ccn2)c2[c-]c(Oc3[c-]c(-n4c(=[Pt])n(-c5c(-c6ccccc6)cccc5-c5ccccc5)c5ccccc54)cc(C(C)(C)C)c3)ccc21
InChIInChI=1S/C54H50N4O.Pt/c1-37-28-30-56(51-33-40(27-29-55-51)53(2,3)4)50-35-43(25-26-45(37)50)59-44-32-41(54(5,6)7)31-42(34-44)57-36-58(49-24-15-14-23-48(49)57)52-46(38-17-10-8-11-18-38)21-16-22-47(52)39-19-12-9-13-20-39;/h8-27,29,31-33,37H,28,30H2,1-7H3;/q-2;
InChIKeyPLDPPDVZKDNHKL-UHFFFAOYSA-N
MW966.10 g/mol
LogP13.86
Rot. Bonds7

About [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum

[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum (PubChem CID 169066649) has the molecular formula C54H50N4OPt-2 and a molecular weight of 966.10 g/mol. Its IUPAC name is [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
PubChem CID169066649
Molecular FormulaC54H50N4OPt-2
Molecular Weight966.10 g/mol
Exact Mass965.36
IUPAC Name[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum
SMILESCC1CCN(c2cc(C(C)(C)C)ccn2)c2[c-]c(Oc3[c-]c(-n4c(=[Pt])n(-c5c(-c6ccccc6)cccc5-c5ccccc5)c5ccccc54)cc(C(C)(C)C)c3)ccc21
InChIInChI=1S/C54H50N4O.Pt/c1-37-28-30-56(51-33-40(27-29-55-51)53(2,3)4)50-35-43(25-26-45(37)50)59-44-32-41(54(5,6)7)31-42(34-44)57-36-58(49-24-15-14-23-48(49)57)52-46(38-17-10-8-11-18-38)21-16-22-47(52)39-19-12-9-13-20-39;/h8-27,29,31-33,37H,28,30H2,1-7H3;/q-2;
InChIKeyPLDPPDVZKDNHKL-UHFFFAOYSA-N
XLogP13.86
TPSA35.22 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms60
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500966.10
LogP ≤ 513.86
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum (CID 169066649) is [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum is CC1CCN(c2cc(C(C)(C)C)ccn2)c2[c-]c(Oc3[c-]c(-n4c(=[Pt])n(-c5c(-c6ccccc6)cccc5-c5ccccc5)c5ccccc54)cc(C(C)(C)C)c3)ccc21.
What is the InChIKey of [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
The InChIKey is PLDPPDVZKDNHKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H50N4O.Pt/c1-37-28-30-56(51-33-40(27-29-55-51)53(2,3)4)50-35-43(25-26-45(37)50)59-44-32-41(54(5,6)7)31-42(34-44)57-36-58(49-24-15-14-23-48(49)57)52-46(38-17-10-8-11-18-38)21-16-22-47(52)39-19-12-9-13-20-39;/h8-27,29,31-33,37H,28,30H2,1-7H3;/q-2;.
What are the key properties of [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum?
[1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum has a molecular weight of 966.10 g/mol, XLogP of 13.86, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-tert-butyl-5-[[1-(4-tert-butyl-2-pyridinyl)-4-methyl-2,3,4,8-tetrahydroquinolin-8-id-7-yl]oxy]benzene-6-id-1-yl]-3-(2,6-diphenylphenyl)benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 169066649), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).